Related Experiment Video
Updated: Aug 14, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Construction and validation of risk models of prognostic genes associated with parthanatos in papillary thyroid
Rui Wang1,2, Li Zhang3, Shuxin Wen4,5
1Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Object:
This study aimed to elucidate the role of parthanatos-related genes (PRGs) in papillary thyroid carcinoma (PTC) and construct a prognostic risk model to guide personalized treatment.
Methods:
Using the GSE33630 dataset, differentially expressed PRGs were identified and analyzed via weighted gene co-expression network analysis (WGCNA) to pinpoint key module genes. Regression analysis selected seven prognostic genes for risk model construction. The model's performance was validated, and a nomogram was developed for survival prediction. Further analyses included clinical feature correlations, immune infiltration, drug sensitivity, gene set enrichment analysis (GSEA), and experimental validation via RT-qPCR.
Results:
Seven prognostic genes (TSHZ3, SERGEF, AKAP12, SGPP2, ASGR1, AK1, PELI2) were identified. The risk model demonstrated robust predictive accuracy, stratifying patients into high- and low-risk groups with significant survival differences. GSEA revealed 29 enriched pathways (e.g., ribosome, focal adhesion), while immune infiltration analysis highlighted CD56 + NK cells and AK1 as key immune correlates. Drug sensitivity screening identified 111 differential therapeutics. Functional analysis indicated AKAP12 had the strongest functional similarity among prognostic genes.
Conclusion:
This study comprehensively mapped PRGs in PTC, established a validated risk model, and provided insights into immune-microenvironment interactions and therapeutic targets, advancing precision oncology for PTC.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer Prevention
Some...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

